Notice of Effectiveness (effect)
23 Mars 2022 - 11:05AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | March 22,
2022 |
---|
Accession Number: | 0001437749-22-006754 |
---|
Submission Type: | POS AM |
---|
CIK: | 0001742927 |
---|
Company Name: | REVIVA PHARMACEUTICALS HOLDINGS, INC. |
---|
File Number: | 333-251802 |
---|
Reviva Pharmaceuticals (NASDAQ:RVPH)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Reviva Pharmaceuticals (NASDAQ:RVPH)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025